HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ridley, P. D. Articles by Yacoub, M. H. Search for Related Content PubMed PubMed Citation Articles by Ridley, P. D. Articles by Yacoub, M. H.

The Annals of Thoracic Surgery, Vol 54, 333-337, Copyright © 1992 by The Society of Thoracic Surgeons

ARTICLES

Heterotopic heart transplantation and recipient heart operation in ischemic heart disease

PD Ridley, A Khaghani, F Musumeci, R Favaloro, ES Akl, NR Banner, AG Mitchell and MH Yacoub
Department of Cardiothoracic Surgery, Harefield Hospital, Middlesex, England.

The role of heterotopic heart transplantation in coronary heart disease has not been defined. Between 1983 and 1988, 28 patients with end-stage ischemic heart disease were managed by heterotopic heart transplantation and adjunctive operation on the recipient heart: coronary artery bypass grafts and aneurysmectomy, 20; coronary artery bypass grafts, 5; and aneurysmectomy, 3. Indications were feasibility of operative procedures to the recipient heart and small donor size (61% of the donors were less than 15 years). The 1-year and 5-year actuarial survival was 79% and 63%. Of the 22 patients who survived to 2-year follow-up, all of whom had been severely limited (New York Heart Association grade III/IV) preoperatively, 20 were in grades I or II at 2-year follow-up (p less than 0.001). In 14 of 22 patients (64%), the recipient heart augmented the donor cardiac output substantially, and in 4 the recipient heart supported the patient when the donor heart failed to eject. In conclusion, this series demonstrates the efficacy of heterotopic transplantation combined with operation to the recipient heart in the management of patients with end-stage ischemic heart disease.

This article has been cited by other articles:

				L. U. Nwakanma, A. S. Shah, J. V. Conte, and W. A. Baumgartner Heart Transplantation Card. Surg. Adult, January 1, 2008; 3(2008): 1539 - 1578. [Full Text]

				A. Al-Khaldi, B. A. Reitz, H. Zhu, and D. Rosenthal Heterotopic Heart Transplant Combined With Postoperative Sildenafil Use for the Treatment of Restrictive Cardiomyopathy Ann. Thorac. Surg., April 1, 2006; 81(4): 1505 - 1507. [Abstract] [Full Text] [PDF]

				A. E. Newcomb, D. S. Esmore, F. L. Rosenfeldt, M. Richardson, and S. F. Marasco Heterotopic Heart Transplantation: An Expanding Role in the Twenty-First Century? Ann. Thorac. Surg., October 1, 2004; 78(4): 1345 - 1350. [Abstract] [Full Text] [PDF]

				B. T. Bethea, D. D. Yuh, J. V. Conte, and W. A. Baumgartner Heart Transplantation Card. Surg. Adult, January 1, 2003; 2(2003): 1427 - 1460. [Full Text]

				A. Kadner, R. H. Chen, and D. H. Adams Heterotopic heart transplantation: experimental development and clinical experience Eur. J. Cardiothorac. Surg., April 1, 2000; 17(4): 474 - 481. [Abstract] [Full Text] [PDF]

				A. Khaghani, R. Casula, N. E. Khan, and M. H. Yacoub Heterotopic heart transplantation through a right thoracotomy Ann. Thorac. Surg., December 1, 1999; 68(6): 2334 - 2336. [Abstract] [Full Text] [PDF]

				C. Schmid, D. Kececioglu, W. Konertz, T. Mollhoff, and H. H. Scheld Biological Bridging After Repair of an Anomalous Origin of a Left Coronary Artery Ann. Thorac. Surg., December 1, 1996; 62(6): 1839 - 1841. [Abstract] [Full Text]